Skip to main content
VCbacked
Log inGet Started

Biological Lattice Industries

Boston, United States

Design & fabrication of implantable architected biomaterials that open new avenues for regenerative medicine.

$1.8M raised
Oct 2024
Pre-Seed
Health CareManufacturingMedical Device

Top Investors

Uni.Fund

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Biological Lattice Industries

How much funding has Biological Lattice Industries raised?
Biological Lattice Industries has raised $1.8M in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2024.
Who are Biological Lattice Industries's investors?
Biological Lattice Industries's investors include Uni.Fund.
Where is Biological Lattice Industries headquartered?
Biological Lattice Industries is headquartered in Boston, United States.
What does Biological Lattice Industries do?
Design & fabrication of implantable architected biomaterials that open new avenues for regenerative medicine.
What stage is Biological Lattice Industries at?
Biological Lattice Industries is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Biological Lattice Industries — Funding & Investors." VCBacked, October 18, 2024, https://www.vcbacked.co/company/biological-lattice-industries. Accessed June 9, 2026.
APA
VCBacked. (2024). Biological Lattice Industries — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/biological-lattice-industries
Wikipedia (cite web)
{{cite web |title=Biological Lattice Industries — Funding & Investors |url=https://www.vcbacked.co/company/biological-lattice-industries |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K